Articolul precedent |
Articolul urmator |
395 12 |
Ultima descărcare din IBN: 2024-03-11 21:26 |
SM ISO690:2012 SAVCA, Marina, POPA, Ana, DOGOT, Marta, ROMANCIUC, Iuliana, CAPROŞ, Natalia. Hipertensiunea arterială preexistentă și impactul asupra severității la pacienții cu COVID-19. In: Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, 21-23 octombrie 2020, Chişinău. Chişinău: USMF, 2020, p. 321. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” 2020 | ||||||
Congresul "Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”" Chişinău, Moldova, 21-23 octombrie 2020 | ||||||
|
||||||
Pag. 321-321 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Background. The prevalence of pre-existing hypertension seems to be higher in COVID-19 patients who develop severe disease versus those who do not. Studies have reported hypertension as one of the most common comorbidities (30%) in patients with COVID19, frequently associated with acute respiratory disorders. Objective of the study. The aim of the study was to assess the presence of hypertension and the impact on severity of patients with COVID-19 Material and Methods. We included 92 inpatients (≥18 years old) in a prospective multicentre cohort hospitalized at Municipal Clinical Hospitals No. 1 and No. 3 (Chisinau, Moldova), the diagnosis being confirmed in laboratories specialized in SARS CoV2 RT-PCR detection. Patients were investigated clinically and paraclinically according to WHO Provisional Forms for reporting COVID-19 infection. Results. Of the 92 cases with COVID-19, (mean age 61.51±3.42 years), without gender predominance (men 51.2% determine the vs 48.8% women), 54 (58.69%) reported at least one cardiovascular comorbidities. The rate of hypertension was (34.7%) and predominated compared to the presence of diabetes (13.04%, p <0.001), cerebrovascular disease (8.6% p <0.001) and chronic obstructive pulmonary disease (17.3%, p <0.001). Stratification of patients by severity revealed the coexistence of pre-existing hypertension in severe vs. non-severe COVID-19 patients (75.92% vs. 59.78%, respectively, p <0.001), with advanced age (81.23 vs 57.33 years, respectively, p <0.001) and death accounting for 7.61%. Conclusion. The presence of hypertension and advanced age in patients with COVID-19 severity of patients and increased mortality. |
||||||
Cuvinte-cheie hypertension, COVID-19, hipertensiunea arterială, COVID-19 |
||||||
|